Cargando…

No association between vitamin D deficiency and parathyroid hormone, bone density and bone turnover in a large cohort of HIV-infected men on tenofovir

INTRODUCTION: Combination antiretroviral therapy (cART) may affect vitamin D [25(OH)D], parathyroid hormone (PTH), bone mineral density (BMD) and bone turnover (BT). Reduced BMD and secondary hyperparathyroidism have been reported with tenofovir (TDF). We investigated the associations between TDF an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Samarawickrama, Amanda, Jose, Sophie, Sabin, Caroline, Walker-Bone, Karen, Fisher, Martin, Gilleece, Yvonne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International AIDS Society 2014
Materias:	Poster Sessions – Abstract P036
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224824/ https://www.ncbi.nlm.nih.gov/pubmed/25394075 http://dx.doi.org/10.7448/IAS.17.4.19568

Ejemplares similares

Learning through COVID19: Using digital technology to compare undergraduate clinical placement competency data, before and during the global pandemic
por: Sharp, J., et al.
Publicado: (2022)

Effets secondaires cutanés du vaccin anti-SARS-CoV2. Expérience chez le personnel soignant du CHU Hassan 2 de Fès
por: El Bennaye, Hajar, et al.
Publicado: (2021)

INFECÇÃO POR SARS‐COV‐2 EM PACIENTES DIABÉTICOS: INTERNAÇÕES, ÓBITOS E LETALDADE NA BAHIA, DE MARÇO A AGOSTO DE 2020
por: Queiroz, Lis Vinhático Pontes, et al.
Publicado: (2021)

Séroprévalence du SARS-CoV-2 chez 3845 patients atteints de rhumatisme inflammatoire chronique : résultats de la cohorte française COVID-RIC 1
por: Pham, T., et al.
Publicado: (2021)

IMPACTO DA PANDEMIA DE COVID-19 NO ACOMPANHAMENTO DE PACIENTES VIVENDO COM HIV
por: Martins, Maria Yasmim Moura, et al.
Publicado: (2022)

Rates of bone fractures in a cohort of HIV-infected adults in the UK
por: Samarawickrama, A, et al.
Publicado: (2010)

High Prevalence of Vitamin D Insufficiency in China: Relationship with the Levels of Parathyroid Hormone and Markers of Bone Turnover
por: Lu, Han-Kui, et al.
Publicado: (2012)

Correlation of vitamin D, bone mineral density and parathyroid hormone levels in adults with low bone density
por: Kota, Sunil, et al.
Publicado: (2013)

Effect of physical training on parathyroid hormone and bone turnover marker profile in relation to vitamin D supplementation in soccer players
por: Brzeziański, Michał, et al.
Publicado: (2021)

The effect of tenofovir on renal function in HIV-positive pregnant women
por: Flanagan, Stuart, et al.
Publicado: (2014)

Daily parathyroid hormone administration enhances bone turnover and preserves bone structure after severe immobilization‐induced bone loss
por: Harlow, Lauren, et al.
Publicado: (2017)

Relationship between Vitamin D, Parathyroid Hormone, and Bone Mineral Density in Elderly Koreans
por: Kim, Guilsun, et al.
Publicado: (2012)

The Calcium-Sensing Receptor Mediates Bone Turnover Induced by Dietary Calcium and Parathyroid Hormone in Neonates
por: Shu, Lei, et al.
Publicado: (2011)

Rectal 1% Tenofovir Gel Use Associates with Altered Epidermal Protein Expression
por: Romas, Laura, et al.
Publicado: (2016)

An indirect comparison of efficacy and safety of elvitegravir/cobicistat/emtricitabine/tenofovir and dolutegravir + abacavir/lamivudine
por: Rogatto, Felipe, et al.
Publicado: (2014)

Co-administration of ritonavir-boosted protease inhibitors and rate of tenofovir discontinuation in clinical practice
por: Costarelli, Silvia, et al.
Publicado: (2014)

Bone turnover in elderly men: relationships to change in bone mineral density
por: Nguyen, Tuan V, et al.
Publicado: (2007)

Should the dose of tenofovir be reduced to 200–250 mg/day, when combined with protease inhibitors?
por: Hill, Andrew, et al.
Publicado: (2014)

Bone turnover predicts change in volumetric bone density and bone geometry at the radius in men
por: Pye, S. R., et al.
Publicado: (2016)

Agreement of Parathyroid Hormone Status Measured by Intact and Biointact Parathyroid Hormone Assays among Chronic Kidney Disease Patients and Its Correlation with Bone Turnover Parameters
por: Hashim, Saidah Madihah, et al.
Publicado: (2023)

Simplification to co-formulated rilpivirine/emtricitabine/tenofovir in virologically suppressed patients: Data from a multicenter cohort
por: Pinnetti, Carmela, et al.
Publicado: (2014)

The impact of tenofovir disoproxil fumarate on kidney function: four-year data from the HIV-infected outpatient cohort
por: Monteiro, Nadine, et al.
Publicado: (2014)

Relationship between body mass index and bone mineral density in HIV-infected patients referred for DXA
por: Pinnetti, Carmela, et al.
Publicado: (2014)

The effect of tenofovir in renal function in HIV-positive adult patients in the Roma health service area, Lesotho, southern Africa
por: Mugomeri, Eltony, et al.
Publicado: (2014)

Failure of daily tenofovir to prevent HIV transmission or the establishment of a significant viral reservoir despite continued antiretroviral therapy
por: Davies, Olubanke, et al.
Publicado: (2014)

Determinants of use of the fixed dose combination emtricitabine/rilpivirine/tenofovir (Eviplera) in HIV-infected persons receiving care in Italy
por: Cozzi-Lepri, Alessandro, et al.
Publicado: (2014)

A Preliminary Study of the Effect of Hyperadrenocorticism on Calcium and Phosphate Concentrations, Parathyroid Hormone and Markers of Bone Turnover in Dogs
por: Mooney, Carmel T., et al.
Publicado: (2020)

Association between abdominal aortic calcifications, bone mineral density and vertebral fractures in a cohort of HIV-positive patients
por: Iannotti, Nathalie, et al.
Publicado: (2014)

Vitamin D, Calcium, Parathyroid Hormone, and Sex Steroids in Bone Health and Effects of Aging
por: Bhattarai, Hitesh Kumar, et al.
Publicado: (2020)

Tenofovir-associated bone density loss
por: Grigsby, Iwen F, et al.
Publicado: (2010)

Changes in Bone Turnover and Bone Loss in HIV-Infected Patients Changing Treatment to Tenofovir-Emtricitabine or Abacavir-Lamivudine
por: Haskelberg, Hila, et al.
Publicado: (2012)

Higher rates of metabolic syndrome among women taking zidovudine as compared to tenofovir in rural Africa: preliminary data from the CART-1 study
por: Labhardt, Niklaus Daniel, et al.
Publicado: (2014)

Serum 25-OH Vitamin D in relation to Bone Mineral Density and Bone Turnover
por: Napoli, Nicola, et al.
Publicado: (2014)

HIV-1 tat and rev upregulates osteoclast bone resorption
por: Chew, Nicholas, et al.
Publicado: (2014)

Prevalence of low bone mineral density among HIV patients on long-term suppressive antiretroviral therapy in resource limited setting of western India
por: Dravid, Ameet, et al.
Publicado: (2014)

Parathyroid hormone 1-34 and skeletal anabolic action: The use of parathyroid hormone in bone formation
por: Osagie-Clouard, L., et al.
Publicado: (2017)

Parathyroid hormone and vitamin D.
por: Harrison, H. E.
Publicado: (1966)

Bone mineral density improvement after 48 weeks of switch to maraviroc+darunavir/ritonavir 300/800/100 mg QD, preliminary results of GUSTA study
por: Bianco, Claudia, et al.
Publicado: (2014)

Relationship between sex hormone levels, bone mineral density and bone turnover markers in healthy moroccan men: a cross-sectional study
por: El Maataoui, Aissam, et al.
Publicado: (2015)

Impact of severity, duration, and etiology of hyperthyroidism on bone turnover markers and bone mineral density in men
por: El Hadidy, El Hadidy M, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_udsc3bnfvddd7kb9pgatbgnohi